No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Thursday, June 12, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Economy

Why The Canadian Govt And Big Pharma Are Waging War On An Ostridge Farm

by TheAdviserMagazine
4 weeks ago
in Economy
Reading Time: 5 mins read
A A
Why The Canadian Govt And Big Pharma Are Waging War On An Ostridge Farm
Share on FacebookShare on TwitterShare on LInkedIn


??LISTEN TO THIS CLIP AND TELL ME THE ATTEPTED OSTRICH CULLING ISN’T THE VACCINE INDUSTRY TRYING TO WIPE OUT COMPETITION?? pic.twitter.com/GYODt61mnO

— Kyle Kemper ? (@kylekemper) May 16, 2025

Post by AgentGuru on X:

Canada’s Ostrich Cull Scandal: Are Big Pharma and Globalist Interests Pulling the Strings?When I first heard about the ostrich farm in Edgewood, British Columbia, facing a forced cull of 400 ostriches, something immediately felt off. Sure, authorities claim they’re responding to an avian flu outbreak—but the deeper I dig into this, the more it smells of something else entirely. Let’s get right into it, because this isn’t just about bird flu—this is about science, censorship, profits, and powerful global interests that seem determined to control the narrative and crush alternatives.

The Edgewood Ostrich Outrage: How We Got Here

Picture a remote, idyllic farm in British Columbia’s Kootenay region, home to about 400 ostriches on 65 acres. On December 31, 2024, two ostriches tragically die of H5N1 avian flu, reportedly brought by wild migratory birds. This leads to a swift quarantine by the Canadian Food Inspection Agency (CFIA)—but that’s just the beginning.

Incredibly, after the initial outbreak, only about 40 birds (roughly 10% of the flock, mainly younger ostriches) succumb to the virus. Within just days, something remarkable occurs: the flock stabilizes, and the remaining 90% of the birds are thriving. Farm owner Karen Espersen observes that these ostriches seem to develop immunity, something clearly special and scientifically fascinating.

Yet despite the farm’s desperate pleas for additional testing and careful scientific study, the CFIA orders all ostriches culled—every last healthy bird—to supposedly “prevent the spread.” The family fights back, but on May 13, 2025, the Canadian Federal Court sides with the CFIA, leaving no room for appeal. The ostriches, despite clear evidence of recovery and possible immunity, are condemned to death.

Why the rush to destroy animals that might be holding keys to groundbreaking treatments? Why no interest in studying them further?

Ostrich Eggs and Antibodies: A Game-Changing Threat to Big Pharma?Here’s where it gets interesting. Ostriches aren’t just giant flightless birds—they are potent biological factories. Their eggs contain powerful antibodies that have already demonstrated incredible therapeutic potential. Each ostrich egg can yield as many antibodies as 100 chicken eggs or 800 rabbits. That’s not just impressive, it’s potentially disruptive to the pharmaceutical industry.

Dr. Yasuhiro Tsukamoto (nicknamed “Dr. Ostrich”), a prominent Japanese veterinary immunologist, has been leading pioneering research using ostrich antibodies. His work, in collaboration with the Edgewood farm, produced breakthrough products during the COVID-19 crisis, including masks and nasal sprays coated with ostrich antibodies that neutralize viruses effectively. Hospitals in Japan even ran successful clinical trials using ostrich antibody nasal sprays for virus prevention.

Now, apply this logic to avian flu—a virus global health authorities (including the WHO and World Economic Forum) are increasingly hyping as “the next COVID,” predicting global outbreaks and calling for new mass vaccination programs. If ostrich antibodies could provide effective natural immunity or treatment against bird flu, that could render new vaccines—particularly expensive, patented mRNA vaccines—unnecessary or less profitable.

It’s not a stretch to see why pharmaceutical giants might perceive ostrich antibodies as a direct threat: cheap, natural, effective, and impossible to monopolize like lab-engineered vaccines.

The Pharma Connection: Is Big Money Silencing Alternative Solutions?As I researched deeper, disturbing questions arose. According to the ostrich farm owners, CFIA officials bizarrely grilled them about their proprietary antibody research during quarantine meetings—unusual questioning, to say the least, for an agency supposedly just concerned with containment. Why was a regulatory agency suddenly so interested in proprietary intellectual property?

From my perspective, this screams of corporate influence—exactly the type of “public-private partnership” favored by groups like the World Economic Forum, where regulatory agencies and pharmaceutical interests often blend seamlessly.

Indeed, ostrich antibodies represent precisely the kind of “inconvenient science” that Big Pharma—and powerful globalist institutions like the WHO and WEF—would rather not let flourish. After all, if a farmer in British Columbia could produce inexpensive antibody-based solutions to avian flu, COVID, or other pandemics, why would governments invest billions in patented mRNA technologies championed by the pharmaceutical establishment?

This dynamic mirrors precisely what we’ve seen throughout COVID: affordable, natural solutions systematically sidelined in favor of profitable, patent-protected vaccines and treatments. And let’s be honest—the upcoming bird flu “crisis” narrative feels suspiciously similar to the lead-up to the COVID pandemic: a hyped-up global threat, new vaccines in the pipeline, and massive profits at stake.

A Pattern of Suppression: “Trust the Science”…or Else?Critically, the CFIA’s rigid refusal to even consider alternative solutions or studies of these potentially immune birds exposes a deeper pattern of institutional inflexibility—or intentional suppression. Despite the farm’s strict quarantine, remote location, and documented immunity of surviving birds, authorities refused any meaningful investigation or testing, stubbornly adhering to blanket policies that conveniently shut down independent science.

Even respected veterinarians like Dr. Scott Weese from the University of Guelph have pointed out the irrationality: “We’re not eradicating H5N1 by culling these ostriches,” he said plainly. Premier David Eby of British Columbia even questioned why there’s no “case-by-case” flexibility, expressing frustration at the CFIA’s blanket policy.

Yet the authorities wouldn’t budge an inch. The message is clear: “Trust our science, no questions allowed.”

Public Outrage and the Fight for TruthThe outrage from the farm, community, and global observers has been intense. Activists and animal advocates descended on Edgewood, physically trying to block the cull and livestreaming desperate pleas for help. Even Robert F. Kennedy Jr., known for challenging the COVID vaccine narrative, weighed in, calling the planned ostrich cull “horrifying.”

The farm’s supporters—and I count myself among them—see this cull as part of a larger pattern: global health authorities and big-money pharmaceutical interests systematically suppressing any inexpensive, natural, and non-patentable solutions. The ostrich antibodies represent exactly the kind of disruptive innovation that global elites, aligned with pharma profits and pandemic narratives, want silenced.

Coincidence or Conspiracy? The Bigger Picture EmergesIs it mere coincidence that, just as ostrich antibodies were demonstrating real promise as inexpensive, natural antiviral solutions, Canadian authorities swiftly moved to destroy the birds producing them?

While no court case or official inquiry directly proves Big Pharma influence on CFIA’s decision, context matters greatly. The aggressive stance of global health organizations promoting the avian flu as “the next big threat,” coupled with heavy investment in mRNA vaccine technology, makes ostrich-derived natural immunity research deeply inconvenient. Powerful financial interests would clearly benefit from removing such competition.

Even Canadian MLAs and animal-rights advocates are questioning whether something darker lies behind this incident. It may not be outright conspiracy—though that can’t be ruled out—but rather the structural, systemic alignment between big-money pharmaceutical interests, compliant government agencies, and international globalist institutions promoting centralized pandemic responses.

Looking Ahead: Fighting for Transparency and Real ScienceThis ostrich farm incident isn’t just another animal culling. It’s a symptom of a broader struggle—science versus profit, freedom versus control, transparency versus censorship.

We have an opportunity to push back, demanding full transparency from government and health authorities. We must insist on fair, unbiased scientific inquiry into promising alternatives, no matter how disruptive they may be to established financial or political interests.

Imagine if Canadian authorities had paused to thoroughly investigate these ostriches’ apparent immunity. Imagine a world where inexpensive, effective ostrich antibodies became a mainstream, natural alternative to costly pharmaceutical vaccines. Unfortunately, this scenario directly threatens too many entrenched interests to be allowed to develop without resistance.

We can’t allow powerful actors to squash independent innovation under the guise of “public health.” The Edgewood ostrich cull should be a wake-up call: it’s about far more than birds—it’s about the future of medical freedom, scientific transparency, and resisting the weaponization of fear-based pandemic narratives for profit and control.

Let’s keep our eyes wide open—and keep digging.





Source link

Tags: bigCanadianFarmGovtOstridgePharmaWagingWar
ShareTweetShare
Previous Post

CME Group set to launch XRP futures on Monday amid legal setback for SEC and Ripple

Next Post

FPIs pump Rs 18,620 cr in equities in May on global tailwinds, improving domestic fundamentals

Related Posts

edit post
Here are the three reasons why tariffs have yet to drive inflation higher

Here are the three reasons why tariffs have yet to drive inflation higher

by TheAdviserMagazine
June 12, 2025
0

Shoppers browse the frozen food cases at WinCo.Joe Jaszewski | Idaho Statesman | Tribune News Service | Getty ImagesDespite widespread...

edit post
The Curious Task – Econlib

The Curious Task – Econlib

by TheAdviserMagazine
June 12, 2025
0

“The curious task of economics is to demonstrate to men how little they really know about what they imagine they...

edit post
Are WNBA Players Underpaid or Overpaid?

Are WNBA Players Underpaid or Overpaid?

by TheAdviserMagazine
June 12, 2025
0

Claudia Goldin is a Harvard labor economist who won the 2023 economics Nobel, and she has a new mission in...

edit post
Is All Economic Growth Good?

Is All Economic Growth Good?

by TheAdviserMagazine
June 12, 2025
0

Yves here. Even though the answer to the headline question seems obvious it’s the sort of thing that can’t be...

edit post
US To Take Ukraine Off Payroll

US To Take Ukraine Off Payroll

by TheAdviserMagazine
June 12, 2025
0

@i.meme.therefore4 ♬ original sound – I Meme Therefore I am While domestic small businesses suffered under Biden-Harris, Ukraine saw a...

edit post
U.S. budget deficit hit 6 billion in May

U.S. budget deficit hit $316 billion in May

by TheAdviserMagazine
June 11, 2025
0

The U.S. Department of the Treasury building is seen in Washington, D.C., on Jan. 19, 2023.Saul Loeb | Afp |...

Next Post
edit post
FPIs pump Rs 18,620 cr in equities in May on global tailwinds, improving domestic fundamentals

FPIs pump Rs 18,620 cr in equities in May on global tailwinds, improving domestic fundamentals

edit post
Q4 results this week: ITC, Sun Pharma, IndusInd Bank, IndiGo, BEL among 81 companies set to announce earnings

Q4 results this week: ITC, Sun Pharma, IndusInd Bank, IndiGo, BEL among 81 companies set to announce earnings

  • Trending
  • Comments
  • Latest
edit post
Squatters Can Legally Take Your Home In These 8 States

Squatters Can Legally Take Your Home In These 8 States

May 18, 2025
edit post
15 “As Seen On TV” Products That Are Well Worth The Money

15 “As Seen On TV” Products That Are Well Worth The Money

May 24, 2025
edit post
LPL, Edward Jones, others to pay M-plus for overcharges

LPL, Edward Jones, others to pay $9M-plus for overcharges

June 10, 2025
edit post
Retiring at 65 Could Become the New Financial Suicide

Retiring at 65 Could Become the New Financial Suicide

May 19, 2025
edit post
Why Baby Boomers Are Hoarding Wealth While Their Kids Can’t Afford Groceries

Why Baby Boomers Are Hoarding Wealth While Their Kids Can’t Afford Groceries

May 24, 2025
edit post
Josh Hawley blasts Allstate CEO for making M last year — while company can’t ‘afford’ to pay out claims

Josh Hawley blasts Allstate CEO for making $26M last year — while company can’t ‘afford’ to pay out claims

May 21, 2025
edit post
What To Know About Trump’s New Cybersecurity Executive Order

What To Know About Trump’s New Cybersecurity Executive Order

0
edit post
Could Trump’s New Tax Bill Spark a Real Estate Revival?

Could Trump’s New Tax Bill Spark a Real Estate Revival?

0
edit post
Kitces & Carl Ep 166: Financial Planners As The Guide To Help Clients Navigate Potentially Changing Terrain?

Kitces & Carl Ep 166: Financial Planners As The Guide To Help Clients Navigate Potentially Changing Terrain?

0
edit post
State and Local Tax Considerations for Businesses

State and Local Tax Considerations for Businesses

0
edit post
Finance Ministry eases rules for bonus share issue by companies in FDI-barred sectors

Finance Ministry eases rules for bonus share issue by companies in FDI-barred sectors

0
edit post
Here are the three reasons why tariffs have yet to drive inflation higher

Here are the three reasons why tariffs have yet to drive inflation higher

0
edit post
Solana-Linked  Billion DeFi Dream Crushed By SEC Intervention

Solana-Linked $1 Billion DeFi Dream Crushed By SEC Intervention

June 12, 2025
edit post
Finance Ministry eases rules for bonus share issue by companies in FDI-barred sectors

Finance Ministry eases rules for bonus share issue by companies in FDI-barred sectors

June 12, 2025
edit post
Mark Zuckerberg has an AI talent problem—but money alone is unlikely to solve it

Mark Zuckerberg has an AI talent problem—but money alone is unlikely to solve it

June 12, 2025
edit post
Confident, Cautious or Confused? What to Make of Mixed Market Signals

Confident, Cautious or Confused? What to Make of Mixed Market Signals

June 12, 2025
edit post
Here are the three reasons why tariffs have yet to drive inflation higher

Here are the three reasons why tariffs have yet to drive inflation higher

June 12, 2025
edit post
What To Know About Trump’s New Cybersecurity Executive Order

What To Know About Trump’s New Cybersecurity Executive Order

June 12, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Solana-Linked $1 Billion DeFi Dream Crushed By SEC Intervention
  • Finance Ministry eases rules for bonus share issue by companies in FDI-barred sectors
  • Mark Zuckerberg has an AI talent problem—but money alone is unlikely to solve it
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.